| Brent Allen Willman, MD | |
|
6041 Village Dr, Suite 150, Lincoln, NE 68516-6619 | |
| (402) 423-1900 | |
| (402) 423-5991 |
| Full Name | Brent Allen Willman |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 6041 Village Dr, Lincoln, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386616092 | NPI | - | NPPES |
| 47081021213 | Medicaid | NE | |
| 00365 | Other | NE | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 17210 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brent Allen Willman, MD 6041 Village Dr, Suite 150, Lincoln, NE 68516-6619 Ph: (402) 423-1900 | Brent Allen Willman, MD 6041 Village Dr, Suite 150, Lincoln, NE 68516-6619 Ph: (402) 423-1900 |
News Archive
A so-called meta-analysis of reports on more than 4,000 patients suggests that almost one in three people discharged from hospital intensive care units (ICUs) has clinically important and persistent symptoms of depression, according to researchers at Johns Hopkins Medicine.
In the study, published in a recent issue of the journal Neurosurgery, 50 percent of stroke patients had little or no neurological disability one to three months after clot-dissolving medication was delivered directly to the site of the blockages, compared to 39 percent of patients with similarly good outcomes documented in a large national trial of intravenous (IV) drug treatment for stroke.
Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in a Phase 3 clinical trial of the investigational drug MDV3100 in advanced prostate cancer. Known as AFFIRM, the trial will evaluate the novel androgen receptor antagonist MDV3100 in men with castration-resistant prostate cancer who were previously treated with docetaxel-based chemotherapy.
Breast-Specific Gamma Imaging (BSGI) significantly contributes to the detection of malignant or high-risk lesions in patients with negative or indeterminate mammographic findings, according to results of a multicenter study presented today at the annual meeting of the Radiological Society of North America (RSNA).
› Verified 6 days ago
Dr. Eileen C Vautravers, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8201 Northwoods Dr, Lincoln, NE 68505 Phone: 405-465-5600 Fax: 402-737-0852 | |
Carmen Jean Mostek, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 6041 Village Dr Ste 150, Lincoln, NE 68516 Phone: 402-423-1900 Fax: 402-423-5991 | |
David Dean Duensing, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7001 A St, Suite 110, Lincoln, NE 68510 Phone: 402-489-0800 Fax: 402-489-6803 | |
Alicia Ann Cruce, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7001 A St, Suite 110, Lincoln, NE 68510 Phone: 402-489-0800 Fax: 402-489-6803 | |
Dr. Stephen R Russell, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3262 Salt Creek Cir, Lincoln, NE 68504 Phone: 402-465-5600 Fax: 402-437-0852 | |
Luke Fletcher Anschutz, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1336 W A St Ste B, Lincoln, NE 68522 Phone: 402-465-5600 Fax: 402-327-6074 | |
Mrs. Shelley Kathleen Nelson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5625 S 62nd St Ste 100, Lincoln, NE 68516 Phone: 402-489-3834 |